Heron Therapeutics, Inc. (HRTX)
0.3321
+0.02
(+6.37%)
USD |
NASDAQ |
Aug 27, 16:00
0.34
+0.01
(+2.38%)
After-Hours: 04:46
Heron Therapeutics EPS Diluted (TTM) : -0.19 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.19 |
| March 31, 2026 | -0.1767 |
| December 31, 2025 | -0.1205 |
| September 30, 2025 | -0.0809 |
| June 30, 2025 | -0.0099 |
| March 31, 2025 | -0.055 |
| December 31, 2024 | -0.0893 |
| September 30, 2024 | -0.1846 |
| June 30, 2024 | -0.3254 |
| March 31, 2024 | -0.6161 |
| December 31, 2023 | -0.87 |
| September 30, 2023 | -0.9654 |
| June 30, 2023 | -1.168 |
| March 31, 2023 | -1.367 |
| December 31, 2022 | -1.718 |
| September 30, 2022 | -2.087 |
| June 30, 2022 | -2.226 |
| March 31, 2022 | -2.296 |
| December 31, 2021 | -2.246 |
| September 30, 2021 | -2.394 |
| June 30, 2021 | -2.520 |
| March 31, 2021 | -2.508 |
| December 31, 2020 | -2.503 |
| September 30, 2020 | -2.470 |
| June 30, 2020 | -2.249 |
| Date | Value |
|---|---|
| March 31, 2020 | -2.272 |
| December 31, 2019 | -2.505 |
| September 30, 2019 | -2.490 |
| June 30, 2019 | -2.562 |
| March 31, 2019 | -2.471 |
| December 31, 2018 | -2.478 |
| September 30, 2018 | -2.933 |
| June 30, 2018 | -3.21 |
| March 31, 2018 | -3.47 |
| December 31, 2017 | -3.66 |
| September 30, 2017 | -3.79 |
| June 30, 2017 | -4.26 |
| March 31, 2017 | -4.63 |
| December 31, 2016 | -4.55 |
| September 30, 2016 | -4.20 |
| June 30, 2016 | -3.59 |
| March 31, 2016 | -3.16 |
| December 31, 2015 | -2.94 |
| September 30, 2015 | -2.78 |
| June 30, 2015 | -2.81 |
| March 31, 2015 | -2.85 |
| December 31, 2014 | -2.89 |
| September 30, 2014 | -2.93 |
| June 30, 2014 | -3.07 |
| March 31, 2014 | -3.29 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Praxis Precision Medicines, Inc. | -12.94 |
| Tonix Pharmaceuticals Holding Corp. | -12.93 |
| ACADIA Pharmaceuticals, Inc. | 2.220 |
| Alnylam Pharmaceuticals, Inc. | 5.923 |
| Anika Therapeutics, Inc. | -0.2741 |